Drug intelligence / Profile preview

Hsc70NTD-TRP2(153-417)

Development stage
Preclinical
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01

Overview

Hsc70NTD-TRP2(153-417) is an experimental recombinant **therapeutic cancer vaccine** fusion protein comprising the N-terminal ATPase domain of murine heat shock cognate protein 70 and amino acids 153-417 of murine tyrosinase-related protein 2, a melanoma-associated tumor-rejection antigen. In a B16 murine melanoma model, the refolded fusion protein retained ATPase activity, induced TRP2-specific cytotoxic T-lymphocyte responses, and delayed tumor growth following immunization. It is a preclinical academic construct rather than a clinically developed or marketed medicine. ([sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S0165247806000848))

Other names
Hsc70NTD-TRP2 153-417Hsc-70NTD-TRP2 153-417Hsc 70NTD-TRP2 153-417Hsc70NTD-TRP2(153-417)Hsc70NTD-TRP2153-417Hsc-70NTD-TRP2153-417Hsc 70NTD-TRP2153-417
02

Targets

TYRP2 (Tyrosinase-related Protein 2)

Beyond the preview

Go deeper on Hsc70NTD-TRP2(153-417).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hsc70NTD-TRP2(153-417).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call